📊 A new COVID-19 variant BA.3.2 (“Cicada”) is drawing atten

📊 A new COVID-19 variant BA.3.2 (“Cicada”) is drawing attention from CDC and WHO — it has already been detected in over 20 countries and accounts for up to 30% of cases in some regions
🧬 The variant is highly mutated (70–75 mutations), which may reduce existing immunity effectiveness, though there is no evidence of increased severity
🌍 In the U.S., its share remains low (~3.7%), but spread continues, with potential for growth amid low vaccination levels
🤒 Symptoms remain typical for COVID (runny nose, cough, sore throat, fatigue), with reports of more severe sore throat
⚠️ The main risk is a potential new wave, though this is not yet confirmed
👉 The variant is not dominant yet, but is under close monitoring and could become a new driver of infections and volatility in the markets. We are looking at S&P 500
$BTC 
BTC
69,167.31
+2.55%

.css-1iqe90x{box-sizing:border-box;margin:0;min-width:0;color:#EAECEF;}📊 A new COVID-19 variant BA.3.2 (“Cicada”) is drawing attention from CDC and WHO — it has already been detected in over 20 countries and accounts for up to 30% of cases in some regions

📊 A new COVID-19 variant BA.3.2 (“Cicada”) is drawing attention from CDC and WHO — it has already been detected in over 20 countries and accounts for up to 30% of cases in some regions